menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
on
April 6, 2024
(updated May 21, 2024)
| Category:
News
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
Click here to download PDF
